Concepedia
Statistics
Publications
4
Citations
173
H-Index
Active since
2017
Affiliations
Dana-Farber Cancer Institute(Current)
Massachusetts General Hospital
Harvard University
Yale Cancer Center
Bridget Fitzpatrick is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pharmacology.
Publications per year
2017–2022
Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET).
Jennifer A. Chan, Jason E. Faris, Janet E. Murphy et al. · Journal of Clinical Oncology · 2017 · 100 citations
Medicine, Oncology, Pharmacology +16
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival
Leonie K. de Klerk, Anuj Patel, Sarah Derks et al. · Journal for ImmunoTherapy of Cancer · 2021 · 30 citations · Full text
Medicine, Oncology, Pharmacology +17
FOLFOX plus ziv‐aflibercept or placebo in first‐line metastatic esophagogastric adenocarcinoma: A double‐blind, randomized, multicenter phase 2 trial
James M. Cleary, Nora Horick, Nadine J. McCleary et al. · Cancer · 2019 · 24 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Open Process Automation: A standards-based, open, secure, interoperable process control architecture
R. Donald Bartusiak, Stephen Bitar, David L. DeBari et al. · Control Engineering Practice · 2022 · 19 citations
Engineering, Information Technology, Systems Engineering +14
1–4 of 4